Curr Hypertens Rep 2016
When it comes to business development, Boerner said the company is "casting a wide net." He added that Bristol Myers Squibb is hoping to build on the core therapeutic areas it knows well, look across different phases of development and focus on "the best, most innovative science that we can find" to tackle difficult-to-treat diseases
Shot in the Arm (Television production)
higher starch, sugar, or salt
As GLP-1 RAs become more prevalent in treating diabetes and patients with cardiovascular disease (CVD) or risk factors for CVD, clinicians will ultimately manage the practical aspects of patient selection, dosing, special considerations, and side effects of these medications
Research Applications of the BPC-157 Peptide Gastric and intestinal mucosal injury models, where BPC-157 is the standard reference compound for studying cytoprotection independent of acid-suppression mechanisms